Registry study for metastatic Colorectal Cancer in order to collect information on the efficacy of the different treatment choices in non operable metastatic colorectal cancer across all the treatment modalities.
Not Applicable
- Conditions
- Health Condition 1: null- Colorectal Cancer
- Registration Number
- CTRI/2014/09/004981
- Lead Sponsor
- TATA MEMORIAL HOSPITA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 1000
Inclusion Criteria
Histological adenocarcinoma of colon &/or rectum with hepatic or extra-hepatic unresectable metastases
-Treatment decision with standard therapy with or without targeted therapy is made prior to inclusion in registry by the respective Investigator & Institute
Exclusion Criteria
As per the Summary of Product Characteristics or product label, locally approved by the Licensing Authority, for every agent
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method TO DESCRIBE TREATMENT CHOICES IN MANAGEMENT OF MCRC PATIENTS <br/ ><br>WITH UNRESECTABLE HEPATIC AND/ OR EXTRA HEPATIC DISEASE, ACROSS TREATMENT LINESTimepoint: 3 years
- Secondary Outcome Measures
Name Time Method -Overall Response Rates <br/ ><br>Resection (R0, R1) and RFA rates <br/ ><br>Progression Free/ Disease Free Survival <br/ ><br>-Overall Survival <br/ ><br>-Safety parameters for mCRC patients <br/ ><br>-Tolerability of the different treatment modalities and regimens used in management of mCRC <br/ ><br>Timepoint: 3year